QPWM
IPSC icon

Quadrant Private Wealth Management’s Century Therapeutics IPSC Stock Holding History

Quadrant Private Wealth Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.1K Hold
20,022
– – 0.01% 173
2026
Q1 		$45.2K Buy
20,022
+4,736
+31% +$9.96K 0.01% 278
2025
Q4 		$15.2K Hold
15,286
– – ﹤0.01% 273
2025
Q3 		$7.61K Hold
15,286
– – ﹤0.01% 252
2025
Q2 		$8.54K Buy
+15,286
New +$8.2K ﹤0.01% 250

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Quadrant Private Wealth Management's IPSC Position: Q2 2026 in Review

Quadrant Private Wealth Management held its Century Therapeutics (IPSC) position steady in Q2 2026 at 20,022 shares worth $49.1K. The position accounts for 0.01% of the portfolio, ranked #173.

Quadrant Private Wealth Management first reported a position in IPSC in Q2 2025 and has held it in 5 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Quadrant Private Wealth Management held 20,022 shares of Century Therapeutics worth $49.1K as of Q2 2026.
  • Quadrant Private Wealth Management left its Century Therapeutics share count unchanged in Q2 2026.
  • Century Therapeutics made up 0.01% of Quadrant Private Wealth Management's portfolio in Q2 2026, its #173 holding.
  • Quadrant Private Wealth Management first reported a position in Century Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Quadrant Private Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.